Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
466 | 15930 | 31.5 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NSAIDS | authKW | 420455 | 5% | 25% | 876 |
2 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | authKW | 304734 | 4% | 23% | 697 |
3 | COX 2 INHIBITORS | authKW | 192717 | 2% | 40% | 252 |
4 | ROFECOXIB | authKW | 155260 | 1% | 45% | 182 |
5 | CYCLOOXYGENASE | authKW | 127945 | 3% | 14% | 483 |
6 | DICLOFENAC | authKW | 125015 | 2% | 20% | 328 |
7 | COXIBS | authKW | 123432 | 1% | 56% | 115 |
8 | CELECOXIB | authKW | 99372 | 2% | 19% | 271 |
9 | IBUPROFEN | authKW | 86050 | 2% | 13% | 340 |
10 | NABUMETONE | authKW | 85248 | 0% | 64% | 70 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 55950 | 35% | 1% | 5653 |
2 | Rheumatology | 23084 | 7% | 1% | 1142 |
3 | Chemistry, Medicinal | 10974 | 8% | 1% | 1344 |
4 | Medicine, General & Internal | 10289 | 13% | 0% | 2088 |
5 | Gastroenterology & Hepatology | 5720 | 6% | 0% | 1032 |
6 | Chemistry, Analytical | 4184 | 8% | 0% | 1333 |
7 | Medicine, Research & Experimental | 2694 | 6% | 0% | 956 |
8 | Toxicology | 834 | 3% | 0% | 473 |
9 | Biochemical Research Methods | 557 | 3% | 0% | 473 |
10 | Urology & Nephrology | 432 | 2% | 0% | 367 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PAIN NUFFIELD ANAESTHET | 55037 | 0% | 55% | 52 |
2 | AB HANCOCK JR MEM CANC | 25391 | 0% | 40% | 33 |
3 | GEORGE M OBRIEN KIDNEY UROL DIS | 16750 | 0% | 49% | 18 |
4 | GEORGE OBRIEN KIDNEY UROL DIS | 9574 | 0% | 100% | 5 |
5 | OFF CLIN TRAINING | 9115 | 0% | 53% | 9 |
6 | CLIN PHARMACOKINET BIOAVAI IL | 7660 | 0% | 100% | 4 |
7 | OXFORD RADCLIFFE HOSP | 6425 | 0% | 21% | 16 |
8 | PAIN NUFFIELD CLIN NEUROSCI | 6326 | 0% | 25% | 13 |
9 | MICROBIAL BIOTRANSFORMAT GRP | 5745 | 0% | 100% | 3 |
10 | STUDI FIS MACROMOL | 5745 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 61963 | 0% | 45% | 72 |
2 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 31833 | 2% | 6% | 284 |
3 | CURRENT MEDICAL RESEARCH AND OPINION | 18806 | 1% | 5% | 211 |
4 | JOURNAL OF CLINICAL PHARMACOLOGY | 13918 | 1% | 4% | 201 |
5 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 11249 | 1% | 3% | 197 |
6 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 10473 | 1% | 4% | 157 |
7 | CLINICAL THERAPEUTICS | 10117 | 1% | 3% | 164 |
8 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 8923 | 1% | 2% | 198 |
9 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 7998 | 1% | 2% | 175 |
10 | JOURNAL OF RHEUMATOLOGY | 6588 | 1% | 2% | 215 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NSAIDS | 420455 | 5% | 25% | 876 | Search NSAIDS | Search NSAIDS |
2 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | 304734 | 4% | 23% | 697 | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS |
3 | COX 2 INHIBITORS | 192717 | 2% | 40% | 252 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
4 | ROFECOXIB | 155260 | 1% | 45% | 182 | Search ROFECOXIB | Search ROFECOXIB |
5 | CYCLOOXYGENASE | 127945 | 3% | 14% | 483 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
6 | DICLOFENAC | 125015 | 2% | 20% | 328 | Search DICLOFENAC | Search DICLOFENAC |
7 | COXIBS | 123432 | 1% | 56% | 115 | Search COXIBS | Search COXIBS |
8 | CELECOXIB | 99372 | 2% | 19% | 271 | Search CELECOXIB | Search CELECOXIB |
9 | IBUPROFEN | 86050 | 2% | 13% | 340 | Search IBUPROFEN | Search IBUPROFEN |
10 | NABUMETONE | 85248 | 0% | 64% | 70 | Search NABUMETONE | Search NABUMETONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, YF , JOBANPUTRA, P , BARTON, P , BRYAN, S , FRY-SMITH, A , HARRIS, G , TAYLOR, RS , (2008) CYCLOXYGENASE-2 SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (ETODOLAC, MELOXICAM, CELECOXIB, ROFECOXIB, ETORICOXIB, VALDECOXIB AND LUMIRACOXIB) FOR OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION.HEALTH TECHNOLOGY ASSESSMENT. VOL. 12. ISSUE 11. P. 1 -+ | 233 | 82% | 102 |
2 | SIMMONS, DL , BOTTING, RM , HLA, T , (2004) CYCLOOXYGENASE ISOZYMES: THE BIOLOGY OF PROSTAGLANDIN SYNTHESIS AND INHIBITION.PHARMACOLOGICAL REVIEWS. VOL. 56. ISSUE 3. P. 387-437 | 203 | 46% | 742 |
3 | STAREK, M , KRZEK, J , (2009) A REVIEW OF ANALYTICAL TECHNIQUES FOR DETERMINATION OF OXICAMS, NIMESULIDE AND NABUMETONE.TALANTA. VOL. 77. ISSUE 3. P. 925-942 | 141 | 92% | 39 |
4 | SCARPIGNATO, C , LANAS, A , BLANDIZZI, C , LEMS, WF , HERMANN, M , HUNT, RH , (2015) SAFE PRESCRIBING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH OSTEOARTHRITIS - AN EXPERT CONSENSUS ADDRESSING BENEFITS AS WELL AS GASTROINTESTINAL AND CARDIOVASCULAR RISKS.BMC MEDICINE. VOL. 13. ISSUE . P. - | 135 | 66% | 20 |
5 | DAVIES, NM , (1998) CLINICAL PHARMACOKINETICS OF IBUPROFEN - THE FIRST 30 YEARS.CLINICAL PHARMACOKINETICS. VOL. 34. ISSUE 2. P. 101 -154 | 194 | 75% | 168 |
6 | SMITH, WL , DEWITT, DL , GARAVITO, RM , (2000) CYCLOOXYGENASES: STRUCTURAL, CELLULAR, AND MOLECULAR BIOLOGY.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 69. ISSUE . P. 145 -182 | 128 | 52% | 1686 |
7 | BROWN, TJ , HOOPER, L , ELLIOTT, RA , PAYNE, K , WEBB, R , ROBERTS, C , ROSTOM, A , SYMMONS, D , (2006) A COMPARISON OF THE COST-EFFECTIVENESS OF FIVE STRATEGIES FOR THE PREVENTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED GASTROINTESTINAL TOXICITY: A SYSTEMATIC REVIEW WITH ECONOMIC MODELLING.HEALTH TECHNOLOGY ASSESSMENT. VOL. 10. ISSUE 38. P. 1 -+ | 143 | 87% | 55 |
8 | LANZA, FL , CHAN, FKL , QUIGLEY, EMM , (2009) GUIDELINES FOR PREVENTION OF NSAID-RELATED ULCER COMPLICATIONS.AMERICAN JOURNAL OF GASTROENTEROLOGY. VOL. 104. ISSUE 3. P. 728 -738 | 86 | 91% | 232 |
9 | LAINE, L , WHITE, WB , ROSTOM, A , HOCHBERG, M , (2008) COX-2 SELECTIVE INHIBITORS IN THE TREATMENT OF OSTEOARTHRITIS.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 38. ISSUE 3. P. 165 -187 | 122 | 82% | 42 |
10 | CHAKRABORTI, AK , GARG, SK , KUMAR, R , MOTIWALA, HF , JADHAVAR, PS , (2010) PROGRESS IN COX-2 INHIBITORS: A JOURNEY SO FAR.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 15. P. 1563-1593 | 115 | 77% | 61 |
Classes with closest relation at Level 2 |